A residues function by recruiting cellular YTHDF proteins, and inhibiting YTHDF binding to viral RNAs therefore inhibits viral replication.
INTRODUCTION
Like proteins and DNA, RNA is subject to a number of covalent modifications that can impact its function, and posttranscriptionally modified nucleotides have indeed been detected on eukaryotic mRNAs (Carlile et al., 2014; Dominissini et al., 2012 Dominissini et al., , 2016 Meyer et al., 2012; Schwartz et al., 2014; Squires et al., 2012) . Of these, the N 6 -methyladenosine (m 6 A) modification is the most common, with an average of 3 m 6 A addition sites per mRNA and with 25% of all cellular mRNAs containing generally multiple m 6 A residues (Desrosiers et al., 1975; Dominissini et al., 2012; Meyer et al., 2012) . The importance of m 6 A is underlined by the fact that this modification is evolutionarily conserved from fungi to plants and animals, and that global inhibition of m 6 A addition is embryonic lethal in plants, insects, and mammals (Meyer and Jaffrey, 2014; Yue et al., 2015) . The posttranscriptional addition of m 6 A to mRNAs occurs predominantly in the nucleus and is mediated by a heterotrimeric protein complex consisting of the two methyltransferase-like (METTL) enzymes, METTL3 and METTL14, and their cofactor, Wilms tumor 1-associated protein (WTAP) (Liu et al., 2014; Meyer and Jaffrey, 2014; Yue et al., 2015) . This complex specifically methylates A residues in the consensus sequence (G/A/U)(G>A) m 6 AC (U/C/A), although only 15% of sites that have this consensus are actually modified, and the level of modification at any given site can vary significantly. In addition to these m 6 A ''writers,'' mammals also encode two RNA demethylases or ''erasers'' called ALKBH5 (a-ketoglutamarate-dependent dioxygenase homolog 5) and FTO (fat mass and obesity associated), which are found predominantly in the nucleus or cytoplasm, respectively (Jia et al., 2011; Zheng et al., 2013) . Finally, the function of m 6 A residues on mRNAs is thought to be primarily mediated by three related cytoplasmic ''reader'' proteins called YTH-domain containing family 1 (YTHDF1), YTHDF2, and YTHDF3 (Meyer and Jaffrey, 2014; Wang et al., 2014; Wang et al., 2015; Yue et al., 2015) . The three YTHDF proteins all contain a conserved carboxy-terminal YTH domain that binds m 6 A and a more variable amino-terminal effector domain of unclear function. While the m 6 A modification of mRNAs is therefore well established and has been suggested to modulate several aspects of RNA metabolism (Meyer and Jaffrey, 2014; Yue et al., 2015) , exactly how m 6 A editing regulates mRNA function remains largely unclear. Importantly, m 6 A modifications appear to be ubiquitous on mRNAs expressed by viruses that replicate in the nucleus, including SV40, the related retroviruses avian sarcoma virus and Rous sarcoma virus (RSV), adenovirus, and influenza A virus (IAV) (Dimock and Stoltzfus, 1977; Kane and Beemon, 1985; Krug et al., 1976; Lavi and Shatkin, 1975; Sommer et al., 1976) . As viruses invariably rapidly evolve to maximize their replication potential, and given that it would be simple to select for viral mutants that lack consensus m 6 A modification sites, this implies that the m 6 A modification of viral mRNAs enhances viral replication by enhancing some aspect(s) of mRNA function. Despite the fact that the identification of m 6 A on viral mRNAs dates back over 40 years, no report has shown that m 6 A affects any aspect of viral mRNA function. Here, we first precisely map m 6 A modification sites on the RNA genome of human immunodeficiency virus 1 (HIV-1) and show that different HIV-1 isolates contain from four to six m 6 A clusters at the extreme 3 0 end of the viral genome, i.e., primarily in the 3 0 untranslated regions (3 0 UTRs) of the various HIV-1 mRNAs. We further present evidence that these 3 0 UTR m 6 A residues enhance HIV-1 gene expression and replication by increasing the steady state level of viral mRNA expression. Finally, we show that HIV-1 is sensitive to the level of YTHDF2 expression in infected T cells, demonstrating enhanced replication when YTHDF2 was overexpressed and strongly reduced replication when the YTHDF2 gene was knocked out by DNA editing. These data demonstrate that the m 6 A modification of HIV-1 plays a key role in promoting its replication and identifies this RNA modification as a potential target for antiviral drug development.
RESULTS

Mapping m 6
A Sites on the HIV-1 Genome Modification of adenosines to m 6 A on viral mRNAs has been reported for a range of viruses that replicate in the nucleus; however, with the exception of RSV, where seven m 6 A addition sites were mapped using biochemical approaches (Kane and Beemon, 1985) , the location of individual m 6 A residues has remained unknown. To map m
6
A modifications in HIV-1, we used the previously described photo-crosslinking-assisted m 6 A sequencing (PA-m 6 A-seq) technique to identify m 6 A residues on the HIV-1 genome in infected human CD4+ CEM-SS T cells. For this experiment, we pulsed HIV-1-infected T cells with the nucleoside 4-thiouridine (4SU), isolated total poly(A) + RNA ( Figure 1A ), bound this RNA with an m 6 A-specific antibody, and crosslinked the antibody to the RNA ( Figure 1B ). RNA fragments bound to the m 6 A antibody were then reverse transcribed and sequenced. We identified several m 6 A sites that were all located in the 3 0 most 1.4 kb of the 9.2 kb HIV-1 RNA genome ( Figure 1C ). Expansion of this region of the HIV-1 genome (Figure 1D ) reveals three major m 6 A peaks located in the overlap region between the env gene and the second coding exon of rev, in the ''U3'' region of the LTR, particularly in the conserved NF-kB binding sites, and finally in the ''R'' region of the LTR coincident with the TAR (trans-activation response) RNA hairpin, though several other minor m 6 A peaks were also visible. The function of m 6 A sites is primarily mediated by the cytoplasmic YTHDF proteins, though other potential nuclear or cytoplasmic m 6 A binding proteins have been reported (Meyer and Jaffrey, 2014; Meyer et al., 2015) . To determine whether any of the m 6 A sites on the HIV-1 genome mapped using PA-m 6 Aseq are bound by one or more of the three YTHDF proteins in living cells, and hence likely to be functionally relevant, we generated clones of the human cell line 293T engineered to express FLAG-tagged versions of green fluorescent protein (GFP), YTHDF1, YTHDF2, or YTHDF3 (see Figure S1A available online). These cells were infected with a pseudotyped stock of the HIV-1 laboratory isolate NL4-3 (Adachi et al., 1986) , cultured for 48 hr, and then incubated with 4SU for a further 16 hr ( Figure 1A ). At this point, the cells were subjected to photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP), using a monoclonal anti-FLAG antibody, followed by deep sequencing ( Figure S1B ) (Hafner et al., 2010) . Analysis of recovered reads detected T-to-C mutations, which are characteristic of crosslinked 4SU residues that have been subjected to reverse transcription, in 45%-60% of all viral reads obtained from the three FLAG-YTHDF expressing clones but in <5% of the reads obtained from the clone expressing FLAG-GFP ( Figure S1C ), consistent with known ability of all three YTHDF proteins, but not GFP, to bind RNA. Alignment of reads bearing T-to-C mutations to the human and HIV-1 genome (reads lacking T-to-C mutations were discarded) revealed that the HIV-1-specific reads showed a mean length of 25 bp (Figure S1D ), which permitted their unequivocal assignment to the viral genome. Further analysis revealed that the HIV-1-specific reads for all three FLAG-tagged YTHDF proteins mapped to four binding clusters located in the 3 0 1.4 kb of the HIV-1 RNA genome, three of which coincided with the three major sites of m 6 A addition mapped by in vitro crosslinking to an m 6 A specific antibody, as described above ( Figures 1C and  D) . Specifically, we noted binding clusters occupied by all three YTHDF proteins in the HIV-1 env/rev overlap, in the LTR NF-kB repeats, and finally in the LTR R region. Of interest, all three YTHDF proteins also bound a site in the HIV-1 nef gene that was only detected as a minor binding site by PA-m 6 A-seq ( Figure 1D ). None of the other, minor binding sites detected by PA-m 6 A-seq were bound at significant levels by any of the three YTHDF proteins. Therefore we can conclude that HIV-1 transcripts are modified by m 6 A editing at several sites located in the 3 0 1.4 kb of the viral RNA genome and that these m 6 A sites are bound in living cells by all three YTHDF effector proteins.
To determine if the m 6 A modification sites mapped on the NL4-3 laboratory isolate were conserved in primary HIV-1 isolates BaL and JR-CSF (Cann et al., 1990; Hwang et al., 1991) , we repeated the PAR-CLIP analysis in the 293T clones expressing either FLAG-YTHDF1 or FLAG-YTHDF2 using pseudotyped stocks of BaL or JR-CSF. Analysis of the BaL isolate showed that all four clusters identified in NL4-3, in the env/rev overlap, in nef, in U3, and in TAR ( Figure 1D ), were conserved in BaL and again bound by both YTHDF1 and YTHDF2 (Figure 2A ). However, we also noted a novel, intense binding site for both YTHDF proteins in the 3 0 segment of nef that overlaps with the LTR U3 region (Figure 2A , labeled BaL1). Sequence analysis revealed that this new site coincides with a consensus m 6 A modification site present in BaL (5-GGA*CC-3 0 ) that is lacking in NL4-3 and JR-CSF ( Figure 2B ).
The analysis of m 6 A editing sites in JR-CSF produced a similar result. Specifically, both YTHDF1 and YTHDF2 bound to the four m 6 A clusters previously identified in NL4-3 (Figure 2A) , while the novel m 6 A site identified in BaL was, as expected, lacking. However, in JR-CSF we identified two additional, novel m 6 A modification sites in the rev/env overlap region (JR-CSF1) and in the nef/U3 overlap region (JR-CSF2). The novel site in the rev/env overlap region again coincided with a novel ''A'' residue, present in JR-CSF but not NL4-3 or BaL, that forms part of an m 6 A consensus editing site (5 0 -GGA*CA-3 0 ) while, in the case of the LTR U3 region target, the novel m 6 A site appeared to arise due to a change from a weaker m 6 A consensus sequence (5 0 -GAA*CU-3 0 ) to a stronger consensus (5 0 -GGA*CU-3 0 ) ( Figure 2C ). In fact, we did detect a low level of YTHDF binding to this site in both NL4-3 and BaL, suggesting that this sequence may be subject to a low level of m 6 A modification in these viral strains (Figure 2A ). In conclusion, these data demonstrate that all four m 6 A clusters identified in the NL4-3 strain of HIV-1 are conserved in the primary isolates BaL and JR-CSF while BaL has also acquired one, and JR-CSF two, novel m 6 A sites, each lacking in the other two virus isolates.
Of particular note is the fact that all YTHDF protein binding sites, including the novel ones present in BaL and JR-CSF, were located in the 3 0 1.4 kb of all three virus strains, with no m 6 A sites being detected in the first 7.8 kb of the genome ( Figures  1D, 1E , and 2A sequences required for poly(A) addition at the R/U5 junction and therefore are predicted to contain the same 3 0 UTRs as HIV-1 mRNAs. As shown in Figure 4A , both indicator plasmids expressed significantly (p < 0.01) higher levels of RLuc protein in transfected 293T cells when the wild-type HIV-1 sequence was utilized, compared to a similar m 6 A-deficient viral sequence.
This effect was particularly notable for the indicator plasmid bearing the shorter viral 3 0 UTR characteristic of the viral early gene products Tat, Rev, and Nef. Importantly, qRT-PCR analysis of the steady-state level of the RLuc mRNA transcribed from these indicator plasmids ( Figure 4B Previously, m 6 A editing has been proposed to either enhance or decrease mRNA stability (Dominissini et al., 2012; Wang et al., 2014) , raising the possibility that m 6 A editing might exert different effects dependent on, for example, RNA sequence context. To address the generalizability of the data shown in Figures 4A-4D , which show a clear enhancing effect of 3 0 UTR m 6 A editing sites of viral origin, we extended our analysis to cellular m 6 A editing sites that we had identified in human mRNAs in the course of our PAR-CLIP analyses (Figures 1 and 2) . Specifically, we identified m 6 A editing sites bound by the three YTHDF proteins in TBP (one cluster), RHOB (two clusters), GPBP1 (two clusters), ASH1L (two clusters), UBE2L3 (two clusters), c-jun (five clusters), and BTBD7 (six clusters). These cellular m 6 A editing sites were cloned into the 3 0 UTR of the RLuc gene, either individually or together, depending on their separation in their normal sequence context, as either the wild-type sequence or with the edited A residues mutated to G. As may be observed ( Figure 4E ), in all nine vectors analyzed we observed significantly lower RLuc activity when the mutant form of these human RNA sequences, lacking a consensus m 6 A addition site(s), was tested, when compared to the wild-type sequence. The observed effect was generally greater the more m 6 A residues were present ( Figure 4E ). While the data shown in Figure 4 A sites are thought to function by recruiting one or more of the YTHDF proteins to the mRNA. Currently, it remains unclear whether these three proteins are functionally distinct, though our data indicate that all three YTHDFs are recruited to each of the m 6 A editing sites identified on the HIV-1 genome (Figures 1 and 2 ), and we also observed this for the cellular m 6 A editing sites listed in Figure 4C (data not shown). If this hypothesis is correct, then tethering of the effector domain of YTHDF1, YTHDF2, and/or YTHDF3 should reproduce the enhancing effect of 3 0 UTR m 6 A editing sites on RLuc expression seen in Figures 4A and 4C . To test this hypothesis, we expressed fusion proteins consisting of the amino-terminal effector domains of YTHDF1, YTHDF2 and YTHDF3 linked to the bacteriophage MS2 coat protein. All three FLAG-tagged fusion proteins were expressed at levels comparable to the FLAG-tagged parental YTHDF proteins and showed the same cytoplasmic localization ( Figure S2D ). When tested in combination with an RLuc indicator plasmid containing MS2 coat protein binding sites inserted into the 3 0 UTR, we saw a 3-to 4-fold enhancement in RLuc expression with all three YTHDF-MS2 fusions when compared to a control GFP-MS2 fusion ( Figure 4F ), thus arguing consensus, but this does not demonstrate that all of these A residues are actually modified. For related data, see Figure S4 .
that recruitment of YTHDF proteins to m 6 A editing sites mediates the positive effect of 3 0 UTRs containing m 6 A sites.
YTHDF Protein Overexpression Enhances HIV-1 Replication
While the experiments presented in Figure 4 argue that the recruitment of cellular YTHDF proteins to m 6 A residues present in the 3 0 UTR of mRNAs can substantially enhance mRNA expression and protein production, these data do not address whether addition of m 6 A also enhances HIV-1 replication. Because the HIV-1 m 6 A editing sites listed in Figure 3 are located in regions of the viral genome that play key roles in viral replication, e.g., the env/rev gene overlap, the NF-kB repeats, and TAR, it is technically difficult to mutate these m 6 A sites without affecting other cis-acting RNA elements, and any reduction in viral replication would therefore be very difficult to interpret.
As an alternative approach, we therefore asked whether overexpression of YTHDF1, YTHDF2, or YTHDF3 might enhance HIV-1 gene expression, presumably by facilitating the recruitment of these proteins to viral m 6 A editing sites. As shown in Figures 5A and 5B, overexpression of the YTHDF proteins substantially enhanced the expression of the HIV-1 Nef, Tat, and Rev mRNAs as well as the full-length viral genomic RNA (gRNA) at both 24 and 48 hr postinfection (hpi) in human 293T cells. This effect was especially marked when analyzing gRNA expression at 48 hpi, with an 6-fold enhancement seen with A binding domain was replaced with the MS2 coat protein, and these were compared to a negative control GFP-MS2 fusion after cotransfection into 293T cells along with a psiCHECK2 dual luciferase vector with and without MS2 binding sites inserted into the RLuc 3 0 UTR. (A-F). Average of from three to six independent experiments with SD indicated. For related data, see Figure S2 . both YTHDF2 and YTHDF3 overexpression. Analysis of viral protein expression at these same time points ( Figures 5C-5F ) revealed a very similar effect. For example, we observed an 6-fold positive effect of YTHDF2 overexpression on p55 Gag expression at 24 hpi and an 5-fold effect of YTHDF3 overexpression ( Figure 5E ). Similarly, we observed an 4-fold increase in HIV-1 p24 capsid expression at 48 hpi for both YTHDF2 and (A and B) qRT-PCR was used to quantify the expression level of the dominant spliced HIV-1 mRNA isoforms encoding Rev, Tat, or Nef as well as the unspliced genomic RNA (gRNA). Assays were performed at 24 hr (A) or 48 hr (B) postinfection (hpi) using 293T cells stably overexpressing GFP (Neg) or one of the three YTHDF proteins (Y1 is YTHDF1 etc). Data were normalized to endogenous GAPDH mRNA. (C and D) Shown are representative western blots from HIV-1 infection experiments similar to those described in (A) and (B). Infected 293T cells overexpressing GFP (Neg) or one of the YTHDF proteins were lysed at 24 hpi or 48 hpi, then probed with an antibody specific for the HIV-1 p24 capsid protein, Nef, the FLAG tag on the overexpressed YTHDF protein, or endogenous b-actin. Shown below the respective bands are actin-normalized quantifications. p55 represents uncleaved HIV-1 Gag polyprotein while p24 is the mature viral capsid (E and F). Shown are quantifications of band intensities from three independent western experiments, similar to those shown in (C) and (D), performed at 24 hpi (E) or 48 hpi (F), with SD indicated. YTHDF3 overexpression. YTHDF1 overexpression exerted a more minor positive effect on viral gene expression (Figures 5E and 5F ), though the level of ectopic expression of these three proteins was comparable ( Figure S2D ).
We next tested whether overexpression or reduced expression of the YTHDF proteins would affect HIV-1 replication in CD4+ T cells. Western analysis of the expression of these three proteins showed a readily detectable level of expression of YTHDF2, low expression of YTHDF1, and no detectable expression of YTHDF3 in the CD4+ T cell line CEM-SS (data not shown), and we therefore focused our attention on YTHDF2.
To examine how YTHDF2 affects HIV-1 replication in culture, we generated two subclones of CEM-SS, one in which the endogenous YTHDF2 gene was mutationally inactivated using CRISPR/Cas (Shalem et al., 2014) (Y2-KO) and a second cell line that overexpresses YTHDF2 by 2-fold after transduction with a lentiviral YTHDF2 expression vector (Y2-OE). Analysis of these two cell lines, and a control CEM-SS cell line transduced with a GFP-expressing lentivirus, revealed comparable levels of CD4 and CXCR4 expression on their cell surface ( Figure S3 ). Nevertheless, analysis revealed a significant decline (p < 0.006) in viral replication in the Y2-KO CEM-SS cells lacking YTHDF2, and a significant enhancement (p < 0.009) in the replication of HIV-1 in the CEM-SS Y2-OE subclone that overexpresses YTHDF2 ( Figures 6A and 6C ). Of note, this increase in viral replication occurred despite the observation of an enhanced viral cytopathic effect in the Y2-OE culture, which reduced the number of T cells when compared to the Y2-KO culture ( Figure 6B ). Western analysis of viral protein expression at 72 hpi with HIV-1 confirmed a substantially higher level of HIV-1 Gag and Nef expression in the Y2-OE subclone, and a substantially lower level of HIV-1 Gag and Nef expression in the Y2-KO subclone, when compared to the control CEM-SS cells ( Figure 6D ). These data therefore further confirm the findings presented in Figure 4 arguing that the m 6 A-mediated recruitment of YTHDF proteins to viral mRNAs enhances their expression and function and demonstrate that YTHDF protein expression is limiting in both 293T and CEM-SS cells. More importantly, these data argue that m 6 A editing, by recruiting YTHDF proteins to HIV-1 transcripts, significantly enhances the replication potential of HIV-1.
DISCUSSION
Although m
6 A editing of viral mRNAs was first reported 40 years ago (Krug et al., 1976) , the ability to precisely map these editing sites has only recently been achieved. Here, we have focused on the pathogenic human lentivirus HIV-1. We first used an in vitro technique, PA-m 6 A-seq , to map m 6 A editing sites on the genome of the HIV-1 laboratory strain NL4-3 using an m 6 A-specific antibody (Figure 1) . We then extended these data by using PAR-CLIP (Hafner et al., 2010) to map binding sites for the three human YTHDF reader proteins on the HIV-1 genome in infected cells (Figure 1) . These experiments identified four clusters on the HIV-1 RNA genome that not only bound all three cellular YTHDF proteins independently but also bound the m 6 Aspecific antibody (Figure 1 Figures 4A-4D , we in fact observed a strong positive effect of the HIV-1 3 0 UTR on indicator gene expression that was entirely lost when the viral m 6 A editing sites were mutated to G. This effect, which was observed in both lymphoid and nonlymphoid cells, was equivalent at both the protein and RNA levels, thus suggesting that m 6 A sites stabilize edited mRNAs. Moreover, this effect was not specific for HIV-1, as m 6 A sites derived from human mRNAs exerted a similar positive effect ( Figure 4E ). Importantly, we were able to phenocopy the observed enhancement in mRNA function induced by 3 0 UTR m 6 A sites by recruiting any one of the three human YTHDF proteins to the 3 0 UTR of an indicator gene by fusion to an RNA binding site derived from the MS2 bacteriophage coat protein ( Figure 4F ), thus arguing that m 6 A sites exert their effect by recruiting YTHDF proteins. Several of the m 6 A editing sites mapped to the HIV-1 RNA genome were localized to sequences that are required for HIV-1 replication for other, unrelated reasons, including the overlap between the env gene and the second coding exon of rev, the LTR NF-kB binding sites, and TAR, and mutational perturbation of any one of these would therefore be likely to reduce viral replication, thus making interpretation of any loss of viral fitness upon mutation of the viral m 6 A sites difficult. To circumvent this problem, and given our evidence that m 6 A sites primarily act to recruit YTHDF proteins (Figures 1 and 5) , we therefore instead asked if overexpression or knockdown of YTHDF proteins, especially YTHDF2, would induce the predicted up or downregulation of HIV-1 replication and gene expression, respectively. As shown most clearly in the CD4+ human T cell line CEM-SS, we indeed observed a striking increase in HIV-1 replication when YTHDF2 was overexpressed (Y2-OE, Figure 6 ) and a marked decline in HIV-1 replication in T cells in which the YTHDF2 gene had been inactivated by DNA editing (Y2-KO, Figure 6 ). Together, these data therefore map several m 6 A editing sites to the 3 0 UTR region of the HIV-1 genome (Figures 1 and 2) , reveal that A editing sites is to recruit YTHDF proteins to the mRNA ( Figure 4F) .
If the m 6 A editing sites in the HIV-1 genome are important for maximizing virus replication, then one would predict that these would be conserved. The four m 6 A editing sites identified in the NL4-3 laboratory strain of HIV-1 were indeed found to be conserved in the primary isolates BaL and JR-CSF, though interestingly these also contained one or two additional m 6 A editing sites not seen in NL4-3 ( Figure 2 ). As regards the four m 6 A binding clusters mapped in all three HIV-1 variants, these each contain either two or three sites that bear the minimal m 6 A editing consensus 5 0 -RA*C-3 0 (Figure 3) . Analysis of the conservation of these ten possible m 6 A addition sites across the A, B, C, and D clades of HIV-1 ( Figure S4A ) shows that seven out of ten sites are highly conserved. Two of the three sites in the LTR U3 region are partly conserved, being found in three out of four of these HIV-1 clades, while one site, the second site in TAR, is only weakly conserved. As this potential TAR m 6 A site is a weak consensus editing site, we actually believe that editing at this site is unlikely. Indeed, the large majority of the crosslinking of all three YTHDF proteins to TAR occurs to the 5 0 arm of TAR ( Figure S1E ), arguing that the optimal m 6 A editing site flanking the bulged A residue at position 17 in the 5 0 arm of TAR is the main target for m 6 A editing ( Figure S4B ). The TAR RNA hairpin forms part of the HIV-1 ''R'' region and is therefore present at both ends of the viral RNA genome (Hauber and Cullen, 1988) . Many of the reads obtained during the YTHDF protein PAR-CLIP experiments extend past the R region into U3, thus demonstrating that the 3 0 TAR is m 6 A edited ( Figure S1E ). While no reads extending past R into U5 were recovered, it remains possible that the TAR m 6 A editing site(s) ( Figure S4 ) is also utilized at the 5 0 end of the HIV-1 genome. This would be of interest given recent data arguing that m 6 A editing sites present in the 5 0 UTR can induce cap-independent translation, including under conditions of cell stress (Meyer et al., 2015) . It has been proposed that HIV-1 mRNAs can also undergo cap-independent translation initiation, despite the existence of a cap at the 5 0 end of all viral mRNAs, yet no HIV-1 internal ribosome entry site has been identified (Monette et al., 2013) . m 6 A editing of the 5 0 TAR element might explain this apparent contradiction. Our observation that m 6 A editing in 3 0 UTRs, and the direct recruitment of the YTHDF proteins to 3 0 UTRs, can significantly enhance the level of mRNA expression and, hence, protein production contrasts with a previous paper arguing that YTHDF2 can destabilize bound mRNAs . We note, however, that earlier work had suggested that loss of m 6 A correlates with the reduced expression of edited transcripts (Dominissini et al., 2012) , which is consistent with our data. While the location of m 6 A residues on a given mRNA, or perhaps their sequence context, could certainly regulate how m A editing sites (Dimock and Stoltzfus, 1977; Kane and Beemon, 1985; Krug et al., 1976; Lavi and Shatkin, 1975; Sommer et al., 1976) . As viruses are under strong selective pressure to maximize their replication potential, and given that the random mutational inactivation of consensus m 6 A editing site would likely occur at high frequency, the observed conservation of the m 6 A editing sites in HIV-1 argues strongly for a positive role in the viral replication cycle. If m 6 A is indeed important for viral replication, then the question arises whether a drug that inhibits m 6 A editing in HIV-1, or indeed other viruses, could act as an effective antiviral. Such a drug does in fact exist. Specifically, 3-deazaadenosine (DAA) has been shown to block m 6 A addition to mRNA substrates by blocking the hydrolysis of S-adenosylhomocysteine, a competitive inhibitor of S-adenosylmethionine, the methyl donor used by the METTL3/METTL14/WTAP complex (Chiang, 1998) . Interestingly, DAA has also been reported to inhibit the replication of a range of viruses, including RSV, IAV, and HIV-1, all of which display extensive m 6 A editing, though the mechanism of inhibition by DAA has remained uncertain (Bader et al., 1978; Fischer et al., 1990; Flexner et al., 1992) . As shown in Figure S5 , we were also able to demonstrate the potent inhibition of HIV-1 replication by DAA. We observed a significant decline in m 6 A levels in total poly(A) + RNA in cells treated with 50 mM DAA ( Figure S5A ), a level that did not reduce cell growth or viability over the 4-day treatment period (Figures S5C and S5D ). Remarkably, this same 50 mM level of DAA effectively inhibited the replication of HIV-1 in CEM-SS cells ( Figure S5B ), a result which copies the reduction in HIV-1 replication seen in CEM-SS cells lacking a functional YTHDF2 gene ( Figure 6 ). While these data do not prove that the sole inhibitory mechanism used by DAA to prevent HIV-1 replication in culture revolves around inhibition of m 6 A editing, they are intriguing in that they suggest that drugs that reduce m 6 A editing might have the potential to inhibit the replication of not only HIV-1 but also other viral pathogens, such as IAV. While this manuscript was under review, Lichinchi et al. (2016) reported that HIV-1 contains 14 m 6 A editing site clusters, 11 of which were reported to be 5 0 to all of the m 6 A sites reported here (Figures 1 and 2 ). These authors focused particularly on two m 6 A sites they identified in the viral Rev response element (RRE) that they proposed regulated RRE function. We did not detect these proposed RRE m 6 A sites in any of our analyses, which used two distinct assays to map m 6 A editing sites on three HIV-1 isolates in two cell lines. While the reason for this discrepancy is currently unclear, it does not result from RRE sequence differences in the viruses analyzed.
EXPERIMENTAL PROCEDURES
Western blots used the following primary antibodies: HIV-1 p24 (AIDS Reagent Program-3517), YTHDF2 (SC-162427, Santa Cruz), Actin (SC-4/778, Santa Cruz), FLAG (F1804, Sigma), and HIV-1 Nef (AIDS Reagent Program-2949). ELISAs utilized an HIV-1 p24 antigen capture kit (ABL Catalog #5421 and 5447). Total poly(A) + RNA was purified using Ambion Poly(A)Purist MAG kits. Cell Culture, HIV-1 Production, and Infections 293T cells were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and antibiotics. CEM-SS cells were cultured in RPMI 1640 containing 10% FBS and antibiotics. HIV-1 was produced by transfection of 293T cells with the pNL4-3 molecular clone; at 72 hr posttransfection, supernatant media were harvested, clarified by centrifugation, and then filtered through a 0.45 mM filter (PALL). To prepare vesicular stomatitis virus glycoprotein (VSV-G) pseudotyped virus, pVSV-G was transfected at a 1:10 ratio relative to an HIV-1 proviral expression vector encoding NL4-3, BaL, or JR-CSF. The supernatant media were harvested 72 hr later, as described above. 293T cells were infected with the HIV-1 virus stock overnight and fresh media added the next morning. CEM-SS subclones were HIV-1 infected overnight, then washed with PBS and resuspended in fresh media next morning. Samples for p24 ELISA and western analysis were collected over time from 6 ml infections per condition/biological replicate.
293T and CEM-SS Clonal Cell Lines
Clonal YTHDF expressing 293T cell lines were produced by transduction with a constitutive lentiviral YTHDF expression vector followed by selection for the encoded puromycin resistance marker. Resistant cells were then sub-cloned by limiting dilution. CEM-SS (NIH AIDS Reagent Program catalog #776) overexpressing YTHDF2 were also obtained by lentiviral transduction and puromycin resistant cells then subcloned by limiting dilution. YTHDF2 overexpression was confirmed by western. YTHDF2 knockout CEM-SS cells were obtained by transduction with lentiCRISPRv2, with the sgRNA sequence 5 0 -GGAACCT TACTTGAGTCCAC-3 0 , obtained from a published library (Shalem et al., 2014) , and were cloned by limiting dilution. The control for these cell lines was a puromycin-selected GFP-expressing CEM-SS subclone.
PAR-CLIP and PA-m 6
A-Seq PAR-CLIP was performed as described (Hafner et al., 2010) . The three clonal 293T cell lines expressing FLAG-YTHDF proteins, or FLAG-GFP as a control, were infected with HIV-1 NL4-3 pseudotyped with VSV-G, incubated for 48 hr, and then pulsed with 100 mM 4SU in fresh media for 16 hr. The cells were then harvested and the PAR-CLIP protocol performed. JR-CSF and BaL infections were conducted similarly. CEM-SS cells were infected with HIV-1, 4SU pulsed, total poly(A) + RNA purified, and the rest of the PA-m 6 A-Seq protocol performed as described using an m 6 A specific polyclonal antibody (SySy). For the indicator plasmid PAR-CLIP experiment shown in Figure S2A , 293T cells expressing FLAG-YTHDF2 were transfected with psiCHECK2-based constructs containing wild-type or mutant forms of the U3/NF-kB/TAR sequence. After 48 hr, the cells were pulsed for 16 hr with 4SU and harvested for PAR-CLIP.
PAR-CLIP libraries were sequenced on a HiSeq 2000; base calling was performed with CASAVA and processed with the fastx toolkit (http://hannonlab. cshl.edu/fastx_toolkit/index.html). Reads >14 bp in length were used for bioinformatic analysis. All alignments were performed with Bowtie (Langmead et al., 2009 ). Reads were initially aligned to the human genome build hg19 allowing up to one mismatch, and unaligned reads were then aligned to the HIV-1 genome of interest, again with one mismatch. The HIV-1 aligned reads exhibited a substantial enrichment of reads containing T>C mutations when derived from cells expressing one of the YTHDF proteins ( Figure S1C ), and these reads were of mean length >24 nt ( Figure S1D ). For all visualizations, only reads containing T>C mutations were considered. Data were processed with in-house Perl scripts and Samtools, and visualized with IGV (Li et al., 2009; Robinson et al., 2011) .
The raw sequencing data obtained from small RNA deep sequencing have been submitted to the NCBI Gene Expression Omnibus (GEO) and are available through accession number GSE77890.
Indicator Assays and MS2 Tethering HIV-1-based indicators were transfected into 293T or CEM-SS cells utilizing the polyethylenimine (PEI) and Lipofectamine LTX (Invitrogen) transfection methods, respectively. Cells were harvested 48 hr later and subjected to either cell lysis using Passive Lysis Buffer-PLB (Promega Dual Luciferase Kit), for protein extraction, or using TRIzol, for total RNA extraction. Protein lysates were analyzed for RLuc and FLuc levels using a Dual Luciferase Assay Kit (Promega). Total RNA was reverse-transcribed using a SuperScript III kit (Invitrogen) followed by SYBR green qPCR of cDNAs utilizing RLuc, FLuc, and GAPDH mRNA-specific primers. RLuc mRNA abundance was determined by normalizing first to the endogenous GAPDH mRNA and then to the control FLuc mRNA. For the tethering assays, 293T cells were transfected with 50 ng psiCHECK2 or the psiCHECK2-4xMS2 reporter and 500 ng pcGFP/MS2, pcYTHDF1/MS2, pcYTHDF2/MS2, or pcYTHDF3/MS2 using PEI. Cells were harvested 72 hr posttransfection and analyzed for RLuc (reporter) and FLuc (internal control) activity using the Dual-Luciferase Assay.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this article online at http://dx.doi.org/10.1016/j.chom.2016.04.002.
AUTHOR CONTRIBUTIONS
E.M.K. and B.R.C. designed experiments, analyzed the data, and wrote the manuscript. E.M.K., H.P.B., A.V.R.K., D.K., D.G., B.C.P., J.B.M., and K.T. performed the experiments, and N.G. and S.M.H. provided reagents.
